Healthcare -
Biotechnology - NASDAQ - US
$ 9.86
-3.8 %
$ 83.8 M
Market Cap
-0.46
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Surrozen, Inc.
| Revenue | 10.7 M |
| Cost Of Revenue | 1.44 M |
| Gross Profit | 9.21 M |
| Operating Expenses | 36.2 M |
| Operating Income | -25.5 M |
| Other Expenses | 38 M |
| Net Income | -63.6 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 10.7 | 0 | 12.5 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.4 | 27.2 | 3.3 | 3.3 | 2.9 | 0 |
| Gross Profit | 9.2 | (27.2) | 9.2 | (3.3) | (2.9) | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 36.2 | 18.6 | 56.8 | 54.4 | 32.8 | 24.8 |
| Selling, General and Administrative Expenses | 15.1 | 15.8 | 19.8 | 14.2 | 7.1 | 5.5 |
| Research and Development Expenses | 21.1 | 27.2 | 37.0 | 40.2 | 25.7 | 19.6 |
| Operating Income | (25.5) | (45.8) | (44.3) | (54.4) | (32.8) | (25.1) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (38.0) | 2.7 | 8.3 | (0.3) | 91 K | 0.7 |
| Pre-Tax Income | (63.6) | (43.0) | (36.0) | (54.6) | (32.7) | (24.4) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (8.3) | (2.1) | 91 K | 0 |
| Net Income | (63.6) | (43.0) | (27.7) | (52.5) | (32.6) | (24.4) |
| EPS | 21.7 | 21.3 | 11.9 | 22.5 | 41 | 61.9 |